aTyr Pharma Announces Third Quarter 2021 Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
aTyr Pharma (LIFE) Tops Q3 EPS by 18c
November 10, 2021 4:47 PM ESTaTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.42), $0.18 better than the analyst estimate of ($0.60).
Cash, cash equivalents and investments as of September 30, 2021 were $116.4 million.
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
... More